Literature DB >> 33489210

A case of congenital single testis with testicular cancer patient and azoospermia who was able to collect spermatozoa with ipsilateral Onco-TESE.

Kazumasa Hayashi1, Teruo Inamoto2, Haruhito Azuma2, Hiroshi Masuda3, Hirotsugu Oku4.   

Abstract

Onco-TESE is a useful strategy for cancer patients with a congenital single testis who wish to preserve their fertility.
© 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Onco‐TESE; cancer patient; congenital single testis; testicular cancer

Year:  2020        PMID： 33489210      PMCID： PMC7813069          DOI： 10.1002/ccr3.3576

Source DB:  PubMed          Journal:  Clin Case Rep        ISSN： 2050-0904


  21 in total

Review 1.  EAU guidelines on testicular cancer: 2011 update.

Authors:  Peter Albers; Walter Albrecht; Ferran Algaba; Carsten Bokemeyer; Gabriella Cohn-Cedermark; Karim Fizazi; Alan Horwich; Maria Pilar Laguna
Journal:  Eur Urol       Date:  2011-05-25       Impact factor: 20.096

2.  Risk of testicular cancer in subfertile men: case-control study.

Authors:  H Møller; N E Skakkebaek
Journal:  BMJ       Date:  1999-02-27

3.  Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.

Authors:  Kutluk Oktay; Brittany E Harvey; Ann H Partridge; Gwendolyn P Quinn; Joyce Reinecke; Hugh S Taylor; W Hamish Wallace; Erica T Wang; Alison W Loren
Journal:  J Clin Oncol       Date:  2018-04-05       Impact factor: 44.544

Review 4.  The impalpable testis: a rational approach to management.

Authors:  S B Levitt; S J Kogan; R M Engel; R M Weiss; D C Martin; R M Ehrlich
Journal:  J Urol       Date:  1978-11       Impact factor: 7.450

5.  Achieved pregnancy with the delivery of a healthy child by TESE-ICSI 7 years after bilateral adult orchidopexy: a case report.

Authors:  K Matsushita; K Yamaguchi; F Li; K Okada; M Ando; K Chiba; M Koshida; H Miyake; M Fujisawa
Journal:  Andrologia       Date:  2013-10-10       Impact factor: 2.775

6.  Improved survival for patients with testicular cancer in Europe since 1978. EUROCARE Working Group.

Authors:  T Aareleid; M Sant; G Hédelin
Journal:  Eur J Cancer       Date:  1998-12       Impact factor: 9.162

Review 7.  Testicular germ-cell cancer.

Authors:  Alan Horwich; Janet Shipley; Robert Huddart
Journal:  Lancet       Date:  2006-03-04       Impact factor: 79.321

8.  Testicular cancer: trends in mortality are well explained by changes in treatment and survival in the southern Netherlands since 1970.

Authors:  R H A Verhoeven; J W W Coebergh; L A L M Kiemeney; E L Koldewijn; S Houterman
Journal:  Eur J Cancer       Date:  2007-10-18       Impact factor: 9.162

9.  Return of fertility after treatment for nonseminomatous testicular cancer: changing concepts.

Authors:  P H Lange; P Narayan; N J Vogelzang; R B Shafer; B J Kennedy; E E Fraley
Journal:  J Urol       Date:  1983-06       Impact factor: 7.450

10.  Onco-testicular sperm extraction (Onco-TESE) from a single testis with metachronous bilateral testicular cancer: a case report.

Authors:  Itsuto Hamano; Shingo Hatakeyama; Rika Nakamura; Rie Fukuhara; Daisuke Noro; Hiroko Seino; Takahiro Yoneyama; Yasuhiro Hashimoto; Takuya Koie; Yoshihito Yokoyama; Chikara Ohyama
Journal:  Basic Clin Androl       Date:  2018-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.